KVLQF yields 2857.14% · PFE yields 6.13%● Live data
📍 KVLQF pulled ahead of the other in Year 1
Combined, KVLQF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KVLQF + PFE for your $10,000?
ValOre Metals Corp., an exploration stage company, engages in the acquisition, exploration, evaluation, and development of mineral resource properties in Canada and Brazil. The company explores for uranium, palladium, platinum, and gold deposits. It holds 100% interests in the Angilak Property that covers an area of 29,595.57 hectares and the Baffin Gold Property that covers an area of 352,727.87 hectares located in Nunavut Territory; the Hatchet Lake Property that consists of 6 claims covering an area of 13,711 hectares located in Saskatchewan; and the Pedra Branca Project that includes 38 exploration licenses covering an area of 38,940 hectares located in north-eastern Brazil. The company was formerly known as Kivalliq Energy Corporation and changed its name to ValOre Metals Corp. in June 2018. ValOre Metals Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.
Full KVLQF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.